Immunophenotypic Features of Myelodysplastic Syndromes by CD45/SSC Gating and Flow Cytometry
LU Rui-nan,LI Jian-yong,WU Yu-jie,ZHU Ming-qing,SONG Jun-hong,GENG Mei-ju
DOI: https://doi.org/10.3969/j.issn.1671-2870.2005.05.011
2005-01-01
Journal of Diagnostics
Abstract:Objective To explore the immunophenotypic features of blasts in the patients with myelodysplastic syndromes (MDS).Methods A panel of monoclonal antibodies and flow cytometry using CD45/SSC gating strategies were used for the immunophenotype in the bone marrow nucleated cells of 54 patients with MDS.Results Of 54 MDS patients,the blasts of 27(50.0%),43(79.6%),39(72.2%),8(14.8%),18(33.3%),4(7.4%) and 3(5.5%) patients had positive expressions of CD34.CD13,CD33,CD2,CD7,CD10 and CD19,separately.There were 100%(9/9),33.3%(3/9),10.6%(5/ 47),25.0%(2/8),7.1%(1/14),5.4%(2/37),and 0%(0/15) of MDS pateints who were positive for HLA-DR,CD117,CD14, CD15,CD3,CD20 and CD22,respectively.However,there was no significant difference in the expression of the above- mentioned antigens on the blasts in the bone marrow between the patients with different MDS subtypes.Conclusions The immunophenotype is an important complementarity to the morphology and cytogenetics for the diagnosis of MDS.